Genfit S.A. Stock
Price
Target price
€3.16
€3.16
-0.940%
-0.03
-0.940%
-
19.04.24 / Tradegate
WKN: A0LGJ2 / Name: Genfit / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Genfit S.A. Stock
The price for the Genfit S.A. stock decreased slightly today. Compared to yesterday there is a change of -€0.030 (-0.940%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Genfit S.A. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Genfit S.A. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Genfit S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Genfit S.A. | -0.940% | -4.683% | -2.773% | -8.683% | -12.483% | -15.370% | -85.724% |
| Ardelyx Inc. | -2.180% | -8.082% | -17.622% | 36.376% | 5.467% | -17.061% | - |
| Salarius Pharmaceuticals Inc. | 1.850% | 7.843% | -16.981% | -69.863% | -20.721% | -98.138% | -99.994% |
| Evolus Inc | -1.830% | -4.386% | -15.504% | 39.744% | 16.578% | 23.164% | - |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-06-19
Upon a preliminary review of the financial statements for Genfit, a company in the Biotechnology & Medical Research industry, it appears that the company has faced some financial challenges in recent years but has managed to show improvements in certain areas. However, a deeper analysis is required to understand the overall financial health of the company and to identify the pros and cons of its financial situation.
*Pros: *
Revenue Growth: Genfit's total revenue increased from €765,000 in 2020 to €80,069,000 in 2021, showing a strong growth trajectory. This demonstrates the company's ability to improve its sales and attract more clients within its industry.
